Essential role of Cdc42 in Ras-induced transformation revealed by gene targeting.

The ras proto-oncogene is one of the most frequently mutated genes in human cancer. However, given the prevalence of activating mutations in Ras and its association with aggressive forms of cancer, attempts to therapeutically target aberrant Ras signaling have been largely disappointing. This lack o...

Full description

Bibliographic Details
Main Authors: Kristy R Stengel, Yi Zheng
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3377703?pdf=render
_version_ 1811206039568121856
author Kristy R Stengel
Yi Zheng
author_facet Kristy R Stengel
Yi Zheng
author_sort Kristy R Stengel
collection DOAJ
description The ras proto-oncogene is one of the most frequently mutated genes in human cancer. However, given the prevalence of activating mutations in Ras and its association with aggressive forms of cancer, attempts to therapeutically target aberrant Ras signaling have been largely disappointing. This lack of progress highlights the deficiency in our understanding of cellular pathways required for Ras-mediated tumorigenesis and suggests the importance of identifying new molecular pathways associated with Ras-driven malignancies. Cdc42 is a Ras-related small GTPase that is known to play roles in oncogenic processes such as cell growth, survival, invasion, and migration. A pan-dominant negative mutant overexpression approach to suppress Cdc42 and related pathways has previously shown a requirement for Cdc42 in Ras-induced anchorage-independent cell growth, however the lack of specificity of such approaches make it difficult to determine if effects are directly related to changes in Cdc42 activity or other Rho family members. Therefore, in order to directly and unambiguously address the role of Cdc42 in Ras-mediated transformation, tumor formation and maintenance, we have developed a model of conditional cdc42 gene in Ras-transformed cells. Loss of Cdc42 drastically alters the cell morphology and inhibits proliferation, cell cycle progression and tumorigenicity of Ras-transformed cells, while non-transformed cells or c-Myc transformed cells are largely unaffected. The loss of Cdc42 in Ras-transformed cells results in reduced Akt signaling, restoration of which could partially rescues the proliferation defects associated with Cdc42 loss. Moreover, disruption of Cdc42 function in established tumors inhibited continued tumor growth. These studies implicate Cdc42 in Ras-driven tumor growth and suggest that targeting Cdc42 is beneficial in Ras-mediated malignancies.
first_indexed 2024-04-12T03:41:01Z
format Article
id doaj.art-6edb5149e0e14855a2c8cbc76a5c394c
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T03:41:01Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-6edb5149e0e14855a2c8cbc76a5c394c2022-12-22T03:49:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0176e3731710.1371/journal.pone.0037317Essential role of Cdc42 in Ras-induced transformation revealed by gene targeting.Kristy R StengelYi ZhengThe ras proto-oncogene is one of the most frequently mutated genes in human cancer. However, given the prevalence of activating mutations in Ras and its association with aggressive forms of cancer, attempts to therapeutically target aberrant Ras signaling have been largely disappointing. This lack of progress highlights the deficiency in our understanding of cellular pathways required for Ras-mediated tumorigenesis and suggests the importance of identifying new molecular pathways associated with Ras-driven malignancies. Cdc42 is a Ras-related small GTPase that is known to play roles in oncogenic processes such as cell growth, survival, invasion, and migration. A pan-dominant negative mutant overexpression approach to suppress Cdc42 and related pathways has previously shown a requirement for Cdc42 in Ras-induced anchorage-independent cell growth, however the lack of specificity of such approaches make it difficult to determine if effects are directly related to changes in Cdc42 activity or other Rho family members. Therefore, in order to directly and unambiguously address the role of Cdc42 in Ras-mediated transformation, tumor formation and maintenance, we have developed a model of conditional cdc42 gene in Ras-transformed cells. Loss of Cdc42 drastically alters the cell morphology and inhibits proliferation, cell cycle progression and tumorigenicity of Ras-transformed cells, while non-transformed cells or c-Myc transformed cells are largely unaffected. The loss of Cdc42 in Ras-transformed cells results in reduced Akt signaling, restoration of which could partially rescues the proliferation defects associated with Cdc42 loss. Moreover, disruption of Cdc42 function in established tumors inhibited continued tumor growth. These studies implicate Cdc42 in Ras-driven tumor growth and suggest that targeting Cdc42 is beneficial in Ras-mediated malignancies.http://europepmc.org/articles/PMC3377703?pdf=render
spellingShingle Kristy R Stengel
Yi Zheng
Essential role of Cdc42 in Ras-induced transformation revealed by gene targeting.
PLoS ONE
title Essential role of Cdc42 in Ras-induced transformation revealed by gene targeting.
title_full Essential role of Cdc42 in Ras-induced transformation revealed by gene targeting.
title_fullStr Essential role of Cdc42 in Ras-induced transformation revealed by gene targeting.
title_full_unstemmed Essential role of Cdc42 in Ras-induced transformation revealed by gene targeting.
title_short Essential role of Cdc42 in Ras-induced transformation revealed by gene targeting.
title_sort essential role of cdc42 in ras induced transformation revealed by gene targeting
url http://europepmc.org/articles/PMC3377703?pdf=render
work_keys_str_mv AT kristyrstengel essentialroleofcdc42inrasinducedtransformationrevealedbygenetargeting
AT yizheng essentialroleofcdc42inrasinducedtransformationrevealedbygenetargeting